Correlation Between Anebulo Pharmaceuticals and Apexigen
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Apexigen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Apexigen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Apexigen, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Apexigen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Apexigen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Apexigen.
Diversification Opportunities for Anebulo Pharmaceuticals and Apexigen
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Anebulo and Apexigen is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Apexigen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apexigen and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Apexigen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apexigen has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Apexigen go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Apexigen
If you would invest 43.00 in Apexigen on November 4, 2024 and sell it today you would earn a total of 0.00 from holding Apexigen or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 5.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Apexigen
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Apexigen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Anebulo Pharmaceuticals and Apexigen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Apexigen
The main advantage of trading using opposite Anebulo Pharmaceuticals and Apexigen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Apexigen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apexigen will offset losses from the drop in Apexigen's long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Apexigen vs. Leap Therapeutics | Apexigen vs. Zura Bio Limited | Apexigen vs. X4 Pharmaceuticals | Apexigen vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |